scPharmaceuticals Inc SCPH:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 10:39 AM EDT
4.54quote price arrow up+0.06 (+1.34%)
Volume
18,922
52 week range
4.25 - 12.29
Loading...
  • Open4.54
  • Day High4.68
  • Day Low4.49
  • Prev Close4.48
  • 52 Week High12.29
  • 52 Week High Date05/15/23
  • 52 Week Low4.25
  • 52 Week Low Date04/18/24

Key Stats

  • Market Cap163.687M
  • Shares Out36.05M
  • 10 Day Average Volume0.15M
  • Dividend-
  • Dividend Yield-
  • Beta0.10
  • YTD % Change-27.46

KEY STATS

  • Open4.54
  • Day High4.68
  • Day Low4.49
  • Prev Close4.48
  • 52 Week High12.29
  • 52 Week High Date05/15/23
  • 52 Week Low4.25
  • 52 Week Low Date04/18/24
  • Market Cap163.687M
  • Shares Out36.05M
  • 10 Day Average Volume0.15M
  • Dividend-
  • Dividend Yield-
  • Beta0.10
  • YTD % Change-27.46

RATIOS/PROFITABILITY

  • EPS (TTM)-1.42
  • P/E (TTM)-3.19
  • Fwd P/E (NTM)-3.07
  • EBITDA (TTM)-55.372M
  • ROE (TTM)-99.97%
  • Revenue (TTM)13.593M
  • Gross Margin (TTM)71.96%
  • Net Margin (TTM)-403.22%
  • Debt To Equity (MRQ)104.28%

EVENTS

  • Earnings Date05/14/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On scPharmaceuticals Inc

 

Profile

MORE
scPharmaceuticals Inc. is a pharmaceutical company. The Company is focused on developing and commercializing products to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The Company develops, internally and through strategic partnerships, products and solutions that aim to expand and advance the outpatient care of select acute conditions. Its lead product candidate, FUROSCIX, consists of its formulation of furosemide delivered via...
Jack Khattar
Independent Chairman of the Board
John Tucker
President, Chief Executive Officer, Director
Rachael Nokes
Chief Financial Officer
Address
25 Burlington Mall Road, Suite 203
Burlington, MA
01803
United States

Top Peers

SYMBOLLASTCHG%CHG
MDWD
Mediwound Ltd
17.62+0.30+1.73%
OMER
Omeros Corp
3.60+0.09+2.42%
RLMD
Relmada Therapeutics Inc
3.64+0.11+3.12%
ETON
Eton Pharmaceuticals Inc
3.50+0.07+2.17%
ELUT
Elutia Inc
3.41+0.12+3.65%